Published: 2022-02-25

Predictors of oocyte yield in controlled ovarian hyperstimulation IVF/ICSI cycles: a retrospective analysis in a tertiary care centre

Reeta Mahey, Ankita Sethi, Neena Malhotra, Neeta Singh, Monica Gupta, Ashish Upadhyay, Neerja Bhatla


Background: The most important predictor of oocyte yield in ART cycles is female age, but other biochemical and ultrasonographic markers done before controlled ovarian stimulation may predict the oocyte yield in women undergoing COS in IVF cycles.

Methods: The main aim of the study was to evaluate ovarian reserve markers before COS which can help to individualise treatment protocols to achieve optimal response and minimise risk of complications. It is retrospective observational study, 1924 women undergoing COS in IVF/ICSI cycles in tertiary care centre in India, from January 2010 to June 2017 were included. 

Results: Univariate analysis showed that age, D2FSH, AMH, D2AFC and E2 on the day of trigger were significant predictors of oocyte yield (p<0.05). E2 on day of trigger with ROC (0.81), indicating good discriminating potential for predicting poor ovarian response, followed by age and D2 FSH. The formula to calculate, number of oocytes retrieved=18.46+(0.174×AFC)+(0.092×AMH)-(0.123×age)-(1.19×FSH), FSH was formulated, with r2=0.2486 (p<0.001). ROC curve analysis shows that FSH has statistically significant discriminability to detect poor response than age [AUC (95% CI) FSH 0.77 (0.74, 0.81), age 0.56 (0.52, 0.60), (p<0.05)]. FSH >7.82 IU/ml was predictor of poor response (sensitivity 78.13%, specificity 79.53%).

Conclusions: A combination of predictors demonstrated superior ability of predicting oocyte yield after controlled ovarian stimulation than compared with any single endocrine marker. D2 FSH though thought to be obsolete, but we found significant predictive ability in terms of oocyte yield in the Indian population.


Ovarian reserve, AMH, AFC, FSH, Oocyte yield, E2 levels

Full Text:



Akande VA. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Human Reproduction. 2002;17(8):2003-8.

Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update. 2006;12(6):685-718.

Penzias A, Azziz R, Bendikson K, Falcone T, Hansen K, Hill M, et al. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and Sterility. 2020;114(6):1151-7.

Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ. Testing ovarian reserve to predict age at menopause. Maturitas. 2009;63(4):280-91.

Kline J, Kinney A, Kelly A, Reuss ML, Levin B. Predictors of antral follicle count during the reproductive years. Human Reproduction. 2005; 20(8):2179-89.

Tsakos E, Tolikas A, Daniilidis A, Asimakopoulos B. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET. Arch Gynecol Obstet. 2014;290(6):1249-53.

Sowers M, McConnell D, Gast K, Zheng H, Nan B, McCarthy JD, et al. Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles. Fertility and Sterility. 2010;94(4):1482-6.

Al-Azemi M, Killick SR, Duffy S, Pye C, Refaat B, Hill N, et al. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Human Reproduction. 2011;26(2):414-22.

Siddhartha N, Reddy Ns, Pandurangi M, Tamizharasi M, Radha V, Kanimozhi K. Correlation of serum estradiol level on the day of ovulation trigger with the reproductive outcome of intracytoplasmic sperm injection. J Hum Reprod Sci. 2016;9(1):23.

Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertility and Sterility. 2008;90(2):395–400.

Li R, Gong F, Zhu Y, Fang W, Yang J, Liu J, et al. Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study. Reproductive BioMedicine Online. 2016;33(4):506-12.